Glaucoma progression at 12 months, measured by additional visual field defects · people with primary angle‐closure suspect
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in IOP measured in mmHg 12 months postintervention · people with primary angle‐closure suspect
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Gonioscopic findings · people with primary angle‐closure suspect
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Need for additional surgery: proportion of participants who received additional surgery to control IOP at 1 year · people with primary angle‐closure suspect
Iridotomy showed no clear difference in need for additional surgery: proportion of participants who received… compared with no iridotomy (low certainty).
1 finding from 1 review
RR 0.5 [0.05, 5.5]
Studies not reported
Low
Mean number of antiglaucoma medications at 1‐year · people with primary angle‐closure suspect
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life measures · people with primary angle‐closure suspect
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with primary angle‐closure suspect
Iridotomy showed no clear difference in adverse events compared with no iridotomy (low certainty).
1 finding from 1 review
RR 13.7 [0.73, 230.42]
Studies not reported
Low
Proportion of participants with IOP control (higher number of events is better) · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
Phacoemulsification may leads to higher proportion of participants with IOP control (higher number of events… compared with laser peripheral iridotomy (low certainty).
1 finding from 1 review
Proportion of participants requiring further IOP‐lowering interventions (additional surgery, medications, or both) (lower number of events is better) · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
It is very uncertain whether phacoemulsification changes proportion of participants requiring further IOP‐lowering… compared with laser peripheral iridotomy (very low certainty).
1 finding from 1 review
Proportion of participants with 1 or more recurrent APAC episodes in the same eye (lower number of events is better) · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
It is very uncertain whether phacoemulsification changes proportion of participants with 1 or more recurrent APAC episodes in… compared with laser peripheral iridotomy (very low certainty).
1 finding from 1 review
Mean number of antiglaucoma medications at 1‐year · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Mean IOP ( · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Mean change in angle findings, measured by any method · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Adverse effects · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Progression of visual field loss (worsening of one or more stages, accordingto the Glaucoma Staging System‐2) (at 12 months) · participants with primary angle‐closure glaucoma
Phacoemulsification probably leads to lower progression of visual field loss (worsening of one or more stages,… compared with laser peripheral iridotomy (moderate certainty).
1 finding from 1 review
OR 0.35 [0.13, 0.91]
Studies not reported
Moderate
Mean change in IOP measured in mmHg 12 months postintervention · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Mean number of antiglaucoma medications at 1‐year · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Gonioscopic findings · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Visual acuity · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Adverse effects · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found